Catalent Provides Business Update and Names Ricky Hopson as Interim Chief Financial Officer
Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, announced a business update. While complete financial information and operating data for the Company’s third fiscal quarter ended March 31, 2023 are not yet finalized, the Company expects that productivity issues and higher-than-expected costs experienced......